Home/Pipeline/PRT-002

PRT-002

Immunology & Oncology

PreclinicalActive

Key Facts

Indication

Immunology & Oncology

Phase

Preclinical

Status

Active

Company

About Protai

AI‑driven proteomics platform accelerating discovery of selective oncology and immunology therapeutics.

View full company profile

Therapeutic Areas

Oncology Immunology